THRASOS INNOVATION INC.

Profile

Company Names

THRASOS INNOVATION INC.

Addresses

7171 FREDERICK BANTING, MONTREAL, A8 H4S 1Z9

Phone Numbers

(450) 682-5140

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2010

State Incorporated:

QUEBEC, CANADA

Total Amount Raised:

$14,000,000.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2015-03-12 
$14,000,000.00 
$21,000,000.00 
$7,000,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
RICHARD 
 
ANDREWS 
EXECUTIVE OFFICER, DIRECTOR
LYNDEN ENERGY CORP   |  THRASOS INNOVATION INC.   |  AZITRA INC   |  GEO TICKET PORTALS, INC.
RAPHAELA (ELA) 
 
BORENSTEIN 
DIRECTOR
THRASOS INNOVATION INC.
JENS 
 
ECKSTEIN 
DIRECTOR
ASCENT THERAPEUTICS INC   |  ALIOS BIOPHARMA INC   |  THRASOS INNOVATION INC.   |  DECIBEL THERAPEUTICS, INC.   |  PALLEON PHARMA INC.   |  PALLEON PHARMACEUTICALS INC.   |  GLADIUS PHARMACEUTICALS CORP   |  AEOVIAN PHARMACEUTICALS, INC.   |  SAMSARA THERAPEUTICS INC.   |  BOSWELL, INC.
JEAN 
 
GEORGE 
DIRECTOR
PORTOLA PHARMACEUTICALS INC   |  ACCELERON PHARMA INC   |  CALITHERA BIOSCIENCES, INC.   |  HYDRA BIOSCIENCES INC   |  CATABASIS PHARMACEUTICALS INC   |  THRASOS INNOVATION INC.   |  GEMINI THERAPEUTICS, INC.   |  CYTEIR THERAPEUTICS, INC.
GAETAN 
 
GRAVEL 
DIRECTOR
THRASOS INNOVATION INC.
DANIEL 
 
HETU 
DIRECTOR
THRASOS INNOVATION INC.   |  GLADIUS PHARMACEUTICALS CORP   |  KALGENE PHAMACEUTICALS INC.
DONALD 
 
NOTMAN 
EXECUTIVE OFFICER
THRASOS INNOVATION INC.   |  OCULAR THERAPEUTIX, INC
JONATHAN 
 
WENER 
DIRECTOR
THRASOS INNOVATION INC.
JOSEPH 
 
ZAKRZEWSKI 
DIRECTOR
PROMEDIOR INC   |  ZELOS THERAPEUTICS INC   |  XCELLEREX, INC.   |  AZELON PHARMACEUTICALS, INC.   |  THRASOS INNOVATION INC.   |  HAPTEN SCIENCES, INC.   |  SITEONE THERAPEUTICS, INC.   |  MACROLIDE PHARMACEUTICALS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2015-03-25
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-03-12 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#